Annual Shareholders Equity
$212.08 M
-$67.44 M-24.13%
31 December 2023
Summary:
Repare Therapeutics annual stockholders equity is currently $212.08 million, with the most recent change of -$67.44 million (-24.13%) on 31 December 2023. During the last 3 years, it has fallen by -$74.75 million (-26.06%). RPTX annual shareholders equity is now -26.47% below its all-time high of $288.42 million, reached on 31 December 2021.RPTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$174.96 M
-$28.72 M-14.10%
30 September 2024
Summary:
Repare Therapeutics quarterly stockholders equity is currently $174.96 million, with the most recent change of -$28.72 million (-14.10%) on 30 September 2024. Over the past year, it has dropped by -$58.41 million (-25.03%). RPTX quarterly shareholders equity is now -44.22% below its all-time high of $313.66 million, reached on 30 June 2020.RPTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.1% | -25.0% |
| 3 y3 years | -26.1% | -19.8% |
| 5 y5 years | +1047.5% | - |
RPTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -26.5% | at low | -42.8% | at low |
| 5 y | 5 years | -26.5% | +559.8% | -44.2% | +400.9% |
| alltime | all time | -26.5% | +559.8% | -44.2% | +400.9% |
Repare Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $174.96 M(-14.1%) |
| June 2024 | - | $203.68 M(-12.2%) |
| Mar 2024 | - | $231.95 M(+9.4%) |
| Dec 2023 | $212.08 M(-24.1%) | $212.08 M(-9.1%) |
| Sept 2023 | - | $233.37 M(-4.9%) |
| June 2023 | - | $245.41 M(-2.3%) |
| Mar 2023 | - | $251.24 M(-10.1%) |
| Dec 2022 | $279.52 M | $279.52 M(-8.6%) |
| Sept 2022 | - | $305.78 M(+35.6%) |
| June 2022 | - | $225.52 M(-12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $258.66 M(-10.3%) |
| Dec 2021 | $288.42 M(+0.6%) | $288.42 M(+32.1%) |
| Sept 2021 | - | $218.25 M(-10.9%) |
| June 2021 | - | $245.09 M(-8.4%) |
| Mar 2021 | - | $267.65 M(-6.7%) |
| Dec 2020 | $286.83 M(-721.8%) | $286.83 M(-4.6%) |
| Sept 2020 | - | $300.80 M(-4.1%) |
| June 2020 | - | $313.66 M(-639.5%) |
| Mar 2020 | - | -$58.13 M(+26.0%) |
| Dec 2019 | -$46.13 M(+106.1%) | -$46.13 M |
| Dec 2018 | -$22.38 M | - |
FAQ
- What is Repare Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Repare Therapeutics?
- What is Repare Therapeutics annual shareholders equity year-on-year change?
- What is Repare Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Repare Therapeutics?
- What is Repare Therapeutics quarterly shareholders equity year-on-year change?
What is Repare Therapeutics annual stockholders equity?
The current annual shareholders equity of RPTX is $212.08 M
What is the all time high annual shareholders equity for Repare Therapeutics?
Repare Therapeutics all-time high annual stockholders equity is $288.42 M
What is Repare Therapeutics annual shareholders equity year-on-year change?
Over the past year, RPTX annual stockholders equity has changed by -$67.44 M (-24.13%)
What is Repare Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of RPTX is $174.96 M
What is the all time high quarterly shareholders equity for Repare Therapeutics?
Repare Therapeutics all-time high quarterly stockholders equity is $313.66 M
What is Repare Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, RPTX quarterly stockholders equity has changed by -$58.41 M (-25.03%)